Pay in 4 interest-free payments of $5.72 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Superior Support We offer a complete satisfaction guarantee
Clin Gastroenterol Hepatol 2025;23:739-47.ArticlePubMed 22
These tests help your provider monitor safety and guide dosing
The people who deserve extra attention usually include: Patients with a known history of diabetic retinopathy Patients with diabetic macular edema Patients with recently worsening retinopathy Patients with poor baseline glucose control who may experience a large A1c drop Patients starting semaglutide while already under retina treatment Patients with multiple high-risk features such as kidney disease, hypertension, or long-standing diabetes In contrast, a patient with type 2 diabetes, no known retinopathy, and a recent normal dilated exam may still need routine follow-upbut often not the same level of concern as someone with active retinal disease
In a separate survey by Omada Health in partnership with Sermo, more than two-thirds (67%) of primary care physicians expressed concern about patients accessing GLP-1 prescriptions for weight loss through a third-party telehealth provider, saying it may put their patients' health at risk
